Mercy Infusion Center - Chippewa — St Louis, Missouri

Mercy Infusion Center - Chippewa is a clinical research site located in St Louis, Missouri, United States 63109.

Crixeo Clinical Trials Trust Score: 32/100 (FAILING). This profile has not yet been claimed by the site owner.

Mercy Infusion Center - Chippewa has participated in 116 clinical trials with 107 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in St Louis

Browse all research sites in Missouri · View every site in St Louis

• University of Illinois at Urbana Champaign
• Washington University; Pediatrics
• Washington Universtiy School of Medicine, Barnes Jewish Hospital
• Washington University and Barnes Jewish Heart & Vascular Center
• Washington University Fertility and Reproductive Medicine Center
• Washinton University in St. Louis
• Washington University/Barnes Jewish Hospital
• Mercy Hospital St. Louis-South
• Washington University-Pediatric Cardiology/ St. Louis Children's Hospital ( Site 0006)
• St. Louis University Eye Institute
• Cardinal Glennon Children's Hospital /Saint Louis University
• Barnes-Jewish Hospital Investigational Drug Service

Sponsor Feasibility Report

Trust Score: 32/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mercy Infusion Center - Chippewa?

Mercy Infusion Center - Chippewa has a Crixeo Trust Score of 32/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mercy Infusion Center - Chippewa conducted?

Mercy Infusion Center - Chippewa has 116 clinical trials on record, with 107 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is Mercy Infusion Center - Chippewa accredited by Crixeo Clinical Trials?

Mercy Infusion Center - Chippewa has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mercy Infusion Center - Chippewa?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.